PHARMALEADS

pharmaleads-logo

Pharmaleads aims to provide patients suffering from severe chronic and acute pain with improved pain relief without the side effects associated with other classes of analgesics. Based on years of experience in the design of highly potent and specific inhibitors of enkephalinases, Pharmaleads has developed a new class of analgesics called DENKIs (Dual Enkephalinases inhibitors). These small molecules are able to provide patients with local and sustainable pain relief. Pharmaleadsโ€™ DENKIs are ... first-in-class drugs with a novel mechanism of action tackling pain by using endogenous enkephalins, natural peptides that specifically bind to pain-related opioid receptors to naturally modulate pain without the side effects observed with exogenous opioid drugs that also bind to other opioids receptors, not involved in pain control, triggering multiple side effects. Pharmaleads believes its products can change the lives of the many patients who are in need of improved treatment options for their chronic and/or acute pain, and could offer healthcare providers with an improved pain management option that helps address the opioid epidemic.

#SimilarOrganizations #People #Website #More

PHARMALEADS

Social Links:

Industry:
Biotechnology Health Care

Founded:
2000-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.pharmaleads.com

Total Employee:
1+

Status:
Active

Contact:
+33 (0)1 44 06 70 00

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics WordPress Content Delivery Network Google Universal Analytics Font Awesome Apache Wordpress Plugins


Similar Organizations

acasti-pharma-logo

Acasti Pharma

Acasti Pharma is an emerging biopharmaceutical company.

not_available_image

Proxima Concepts group of companies

Proxima concepts limited is an international bio pharmaceutical industry.

Current Employees Featured

bernard-roques_image

Bernard Roques
Bernard Roques Co-Founders @ Pharmaleads
Co-Founders

marie-claude-fournie-zaluski_image

Marie-claude Fournie-zaluski
Marie-claude Fournie-zaluski Co-Founder @ Pharmaleads
Co-Founder

Founder


bernard-roques_image

Bernard Roques

marie-claude-fournie-zaluski_image

Marie-claude Fournie-zaluski

Official Site Inspections

http://www.pharmaleads.com Semrush global rank: 5.28 M Semrush visits lastest month: 1.56 K

  • Host name: ns3302486.ip-5-135-158.eu
  • IP address: 5.135.158.131
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "Pharmaleads"

Pharmaleads - Crunchbase Company Profile & Funding

Pharmaleads believes its products can change the lives of the many patients who are in need of improved treatment options for their chronic and/or acute pain, and could offer healthcare โ€ฆSee details»

Pharmaleads - LinkedIn

Pharmaleadsโ€™ mission is to provide precision medicine to relieve the suffering associated with acute and chronic pain. Through the development of our proprietary Dual ENKephalinase Inhibitors ...See details»

Board of Directors - Pharmaleads

See details»

Promotion of a new management team at Pharmaleads to โ€ฆ

About Pharmaleads Headquarted in Paris, Pharmaleads is a clinical stage, private biotech company creating and developing innovative non-opiate, non-addictive products for the โ€ฆSee details»

Pharmaleads 2025 Company Profile: Valuation, โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Pharmaleads. Use the PitchBook Platform to explore the full profile.See details»

Pharmaleads - VentureRadar

"Pharmaleads designs and develops innovative, non-opiate medicines for the management of acute and chronic severe pain, a growing market with significant unmet medical needs.See details»

Pharmaleads - Craft

Pharmaleads is a pharmaceutical company developing non-opiate medicines for the management of acute and chronic severe pain. Its products are designed for the treatment of neuropathic โ€ฆSee details»

PHARMALEADS Company Profile | PARIS, ILE DE FRANCE, France ...

Find company research, competitor information, contact details & financial data for PHARMALEADS of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & โ€ฆSee details»

PHARMALEADS (SCEAUX) Chiffre d'affaires, résultat, bilans sur โ€ฆ

Jul 4, 2017 PHARMALEADS, SA à conseil d'administration est active depuis le 29/12/2000 (24 ans). Établie à SCEAUX - 92330, elle est spécialisée dans le secteur d'activité Recherche โ€ฆSee details»

Pharmaleads - Products, Competitors, Financials, Employees ...

About Pharmaleads Pharmaleads develops non-opiate medicines for pain management in the pharmaceutical industry. The company creates Dual ENKephalinase Inhibitors (DENKIs) that โ€ฆSee details»

Contact & find us - Pharmaleads

Promotion of a new management team at Pharmaleads to accelerate the development of its pain relief drug candidates Nouvelle équipe de direction chez Pharmaleads pour accélérer le โ€ฆSee details»

Pharmaleads - Contacts, Employees, Board Members, Advisors

Pharmaleads is an emerging pharmaceutical company.See details»

Pharmaleads | VentureRadar

Pharmaleads designs and develops innovative, non-opiate medicines for the management of acute and chronic severe pain, a growing market with significant unmet medical needs.See details»

Pharmaleads SA - Drug pipelines, Patents, Clinical trials - Synapse

Explore Pharmaleads SA with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, โ€ฆSee details»

IACTA Pharmaceuticals and Pharmaleads to Develop the World's โ€ฆ

Jan 7, 2021 About Pharmaleads Headquartered in Paris, Pharmaleads, with its sister company Pharmaleads Greater China, is a clinical stage private biotech company creating and โ€ฆSee details»

PHARMALEADS - Biotech.info

Pharmaleads designs and develops innovative, non-opiate medicines for the management of acute and chronic severe pain, a growing market with significant unmet medical needs.See details»

Canada Leads: UHN launches strategy to attract world-leading, โ€ฆ

Apr 7, 2025 In a bold move to position Canada as the ultimate destination for the brightest minds in medical research, whose work will help build our future economy, UHN is unveiling the โ€ฆSee details»

Pipeline Chart - Pharmaleads

Promotion of a new management team at Pharmaleads to accelerate the development of its pain relief drug candidates Nouvelle équipe de direction chez Pharmaleads pour accélérer le โ€ฆSee details»

Our vision - Pharmaleads

Pharmaleads aims to provide patients suffering from severe chronic and acute pain with improved pain relief without the side effects associated with other classes of analgesics. Based on years โ€ฆSee details»

Cutting-Edge pain relief - Pharmaleads

Pr. Roques, a co-founder of Pharmaleads and a well-recognised leader in the understanding of the role of enkephalins in relation to local pain relief, discovered that enkephalins, once โ€ฆSee details»

linkstock.net © 2022. All rights reserved